Abstract
Dendritic cells (DC) are antigen-presenting cells coordinating the interplay of the innate and the adaptive immune response. The endocytic C-type lectin receptors DC-SIGN and Langerin display expression profiles restricted to distinct DC subtypes and have emerged as prime targets for next-generation immunotherapies and anti-infectives. Using heteromultivalent liposomes copresenting mannosides bearing aromatic aglycones with natural glycan ligands, we serendipitously discovered striking cooperativity effects for DC-SIGN(+) but not for Langerin(+) cell lines. Mechanistic investigations combining NMR spectroscopy with molecular docking and molecular dynamics simulations led to the identification of a secondary binding pocket for the glycomimetics. This pocket, located remotely of DC-SIGN's carbohydrate bindings site, can be leveraged by heteromultivalent avidity enhancement. We further present preliminary evidence that the aglycone allosterically activates glycan recognition and thereby contributes to DC-SIGN-specific cell targeting. Our findings have important implications for both translational and basic glycoscience, showcasing heteromultivalent targeting of DCs to improve specificity and supporting potential allosteric regulation of DC-SIGN and CLRs in general.
Original language | English |
---|---|
Pages (from-to) | 18977-18988 |
Number of pages | 12 |
Journal | Journal of the American Chemical Society |
Volume | 143 |
Issue number | 45 |
DOIs | |
Publication status | Published - 17 Nov 2021 |
Austrian Fields of Science 2012
- 301207 Pharmaceutical chemistry
Keywords
- ALLOSTERIC NETWORK
- C-TYPE LECTIN
- CROSS-PRESENTATION
- DENDRITIC CELLS
- DESIGN
- FIMH ANTAGONISTS
- IN-VITRO
- LANGERHANS CELLS
- RECEPTOR
- URINARY-TRACT-INFECTIONS